Cardiol Therapeutics Inc.

General ticker "CRDL" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $141.7M (TTM average)

Cardiol Therapeutics Inc. follows the US Stock Market performance with the rate: 37.4%.

Estimated limits based on current volatility of 4.1%: low 0.88$, high 0.96$

Factors to consider:

  • Total employees count: 18 (+5.9%) as of 2024
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.53$, 1.43$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.45$, 1.26$]

Financial Metrics affecting the CRDL estimates:

  • Positive: with PPE of -3.5 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: negative Operating cash flow
  • Positive: -0.07 < Investing cash flow per share per price, % of -0.02
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
  • Negative: 68.95 < Shareholder equity ratio, % of 75.69 <= 81.82
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term CRDL quotes

Long-term CRDL plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue CA$0.00MM CA$0.00MM CA$0.00MM
Operating Expenses CA$22.47MM CA$40.28MM CA$34.32MM
Operating Income CA$-22.47MM CA$-40.28MM CA$-34.32MM
Non-Operating Income CA$1.25MM CA$3.60MM CA$0.50MM
R&D Expense CA$10.73MM CA$14.01MM CA$14.02MM
Income(Loss) CA$-21.22MM CA$-36.68MM CA$-33.82MM
Net Income(Loss)* CA$-28.13MM CA$-36.68MM CA$-33.82MM
Stockholders Equity CA$28.25MM CA$24.73MM CA$17.88MM
Assets CA$36.70MM CA$31.86MM CA$23.62MM
Operating Cash Flow CA$-25.18MM CA$-25.06MM CA$-23.85MM
Capital expenditure CA$0.06MM CA$0.02MM CA$0.02MM
Investing Cash Flow CA$-0.06MM CA$-0.02MM CA$-0.02MM
Financing Cash Flow CA$-0.06MM CA$18.84MM CA$15.54MM
Earnings Per Share** CA$-0.44 CA$-0.51 CA$-0.39

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.